Drug major Cipla on Wednesday said it had signed a licensing agreement with Belgium-based MultiG for distribution of their COVID-19 rapid antibody test kit, Covi-G, across...
Simplus intends to integrate the vaccine management solution with testing and contact tracing to complete an overarching containment strategy. Simplus, an Infosys company, on Thursday said...
U.S. and European regulators could approve Pfizer PFE.N and BioNTech’s 22UAy.DEBNTX.O experimental COVID-19 vaccine as early as mid-December, the German firm’s chief executive said on Wednesday,...
Final results from Pfizer Inc’s PFE.N COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way...
Qiagen has launched its NeuMoDx Flu A-B/RSV/SARS-CoV-2 vantage test for rapid identification and differentiation between common seasonal flu and Covid-19 in Europe. The molecular diagnostics firm...
Cipla Limited announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across...
Mentice AB has signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), a provider of replication solutions allowing endovascular procedures...
Medtronic plc, the global leader in medical technology, today announced the launch of InPen integrated with real-time Guardian Connect CGM data. InPen is the first and...
Agappe Diagnostics, a Kochi-based company, will soon make 10 lakh RT-LAMP (Reverse Transcription Loop-mediated Isothermal Amplification) based test kits of reagents and supportive equipment available for...
A front-runner coronavirus vaccine developed by drug giant Pfizer and German biotechnology firm BioNTech was more than 90 percent effective at protecting people compared with a...
Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd CIPL.NS said on Monday, even as experts remain...
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in...
Biocon on Saturday said its subsidiary Biocon Biologics has approved a Rs 1,125 crore investment from Goldman Sachs. This capital injection by Goldman Sachs will enable Biocon...
Cipla, the market leader in respiratory therapies, expects a surge in demand for respiratory drugs and inhalers during the coming months when the winter and an...
Seeing a sharp rise in the demand for its suite of nutraceutical products post the Covid-19 outbreak, Bengaluru based Juggat Pharma will be investing Rs 60 crore in...
Copyright © 2024 Medical Buyer